da Vinci Single-Port Transoral Robotic Surgery in European Practice: Early Outcomes and Comparison With Transoral Laser Microsurgery.

Authors

Matthew E Ryan, Matthew Zammit, Kristijonas Milinis, Omar Ahmed, Rupali Sawant, Ava Gubbay, Somer Scott-Clarkson, Harishanker Jeyarajan, Terry M Jones, Mark Wilkie, Katharine Davies, Christopher Loh, Jason C Fleming

Published in

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. Oct 08, 2026. Epub Oct 08, 2026.

Abstract

To report early outcomes following implementation of a da Vinci Single-Port transoral robotic surgery (SP-TORS) programme in the United Kingdom. To provide contextual benchmarking, outcomes were compared with a historical institutional cohort treated using transoral laser microsurgery (TLM).
Retrospective institutional series with comparison against a historical cohort using stabilised inverse-probability-of-treatment weighting.
High-volume UK Tertiary Head and Neck Centre.
All patients undergoing SP-TORS between April 2024 and September 2025. Comparative analyses were limited to oncological resections and included 33 SP-TORS and 61 TLM cases.
Feasibility, peri-operative safety, postoperative haemorrhage, return to theatre, mortality, length of stay, time to oral diet, margin status and adjuvant therapy use.
Sixty-six patients underwent SP-TORS. All procedures were completed transorally without unplanned conversion or peri-operative mortality. Postoperative haemorrhage occurred in 4.5%, with one return to theatre. Length of stay did not differ between groups. Time to oral diet was longer following SP-TORS (adjusted ratio 1.51, p= 0.005). ASCO-defined involved margins were similar (OR 0.30, 95% CI 0.06-1.56; p = 0.15), whereas specimen ink-positive margins were less frequent following SP-TORS (OR 0.31, 95% CI 0.11-0.91; p = 0.03). A sensitivity analysis using propensity-matched T1/T2 pairs demonstrated a consistent directional effect, though this did not reach significance in the smaller matched cohort. Adjuvant therapy use was comparable.
SP-TORS implementation in a high-volume UK centre was feasible and safe during early adoption, with low complication rates. Peri-operative and early functional outcomes were broadly comparable with TLM. Although specimen ink-positive margins were less frequent following SP-TORS, interpretation should be cautious given the historical comparator and associated differences in departmental workflow. These findings support safe integration of SP-TORS into transoral surgical practice and justify prospective evaluation.

PMID:
42849884
Bibliographic data and abstract were imported from PubMed on 09 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.